(Q36177722)

English

Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

George Tomlinson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Moskovitz DN

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Osiowy C

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Giles E

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Heathcote EJ

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 July 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

398-404

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Determinants for sustained HBeAg response to lamivudine therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Viral features of lamivudine resistant hepatitis B genotypes A and D.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Long-term therapy of chronic hepatitis B with lamivudine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Hepatitis B genotypes and the response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00613.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2005.00613.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15985011%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36177722&oldid=1983328855"